TMEM225
gene geneOn this page
Also known as PMP22CDPPP1R154SPATA47
Summary
TMEM225 (transmembrane protein 225, HGNC:32390) is a protein-coding gene on chromosome 11q24.1, encoding Transmembrane protein 225 (Q6GV28). Probably inhibits protein phosphatase 1 (PP1) in sperm via binding to catalytic subunit PPP1CC.
Predicted to enable protein phosphatase 1 binding activity and protein phosphatase inhibitor activity. Predicted to be involved in negative regulation of phosphatase activity. Predicted to be located in inner acrosomal membrane and outer acrosomal membrane.
Source: NCBI Gene 338661 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 36 total
- MANE Select transcript:
NM_001013743
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32390 |
| Approved symbol | TMEM225 |
| Name | transmembrane protein 225 |
| Location | 11q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PMP22CD, PPP1R154, SPATA47 |
| Ensembl gene | ENSG00000204300 |
| Ensembl biotype | protein_coding |
| Entrez | 338661 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000375026, ENST00000528595
RefSeq mRNA: 2 — MANE Select: NM_001013743
NM_001013743, NM_001363605
CCDS: CCDS31697
Canonical transcript exons
ENST00000375026 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001465526 | 123882920 | 123883352 |
| ENSE00001465528 | 123884075 | 123884209 |
| ENSE00001465531 | 123884490 | 123884636 |
| ENSE00001465534 | 123885245 | 123885670 |
Expression profiles
Bgee: expression breadth broad, 19 present calls, max score 93.42.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0515 / max 53.6791, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 122924 | 0.0515 | 3 |
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 93.42 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.40 | silver quality |
| left testis | UBERON:0004533 | 80.79 | gold quality |
| testis | UBERON:0000473 | 78.91 | gold quality |
| right testis | UBERON:0004534 | 77.87 | gold quality |
| adult organism | UBERON:0007023 | 73.45 | gold quality |
| buccal mucosa cell | CL:0002336 | 66.66 | silver quality |
| kidney epithelium | UBERON:0004819 | 63.36 | gold quality |
| cerebellar vermis | UBERON:0004720 | 60.90 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.33 | gold quality |
| tibialis anterior | UBERON:0001385 | 53.12 | silver quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| ileal mucosa | UBERON:0000331 | 50.00 | silver quality |
| pancreatic ductal cell | CL:0002079 | 49.08 | silver quality |
| deltoid | UBERON:0001476 | 48.76 | gold quality |
| quadriceps femoris | UBERON:0001377 | 48.07 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 46.66 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.71 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.07 | silver quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| thymus | UBERON:0002370 | 43.15 | gold quality |
| upper leg skin | UBERON:0004262 | 43.00 | silver quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 42.46 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 42.02 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.05 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting TMEM225, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-298 | 99.63 | 67.56 | 1916 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-2276-3P | 98.76 | 67.75 | 1384 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem225 | ENSMUSG00000040541 |
| rattus_norvegicus | Tmem225 | ENSRNOG00000054439 |
Protein
Protein identifiers
Transmembrane protein 225 — Q6GV28 (reviewed: Q6GV28)
All UniProt accessions (2): E9PLT9, Q6GV28
UniProt curated annotations — full annotation on UniProt →
Function. Probably inhibits protein phosphatase 1 (PP1) in sperm via binding to catalytic subunit PPP1CC.
Subunit / interactions. Interacts (via RVxF motif) with PPP1CC.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome membrane.
RefSeq proteins (2): NP_001013765, NP_001350534 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR033542 | TM225 | Family |
| IPR057351 | TM225_dom | Domain |
Pfam: PF25452
UniProt features (13 total): topological domain 5, transmembrane region 4, sequence variant 2, chain 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6GV28-F1 | 76.30 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
GOCC_SECRETORY_GRANULE, GOCC_ACROSOMAL_MEMBRANE, GOCC_SECRETORY_VESICLE, GOCC_SECRETORY_GRANULE_MEMBRANE, GOCC_ACROSOMAL_VESICLE, chr11q24, MIR196A_1_3P, MIR587, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN, GSE18148_CBFB_KO_VS_WT_TREG_DN, GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP, GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN, GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN, GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP, GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP
GO Biological Process (1): negative regulation of phosphatase activity (GO:0010923)
GO Molecular Function (0):
GO Cellular Component (3): acrosomal membrane (GO:0002080), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of phosphatase activity | 1 |
| phosphatase activity | 1 |
| negative regulation of dephosphorylation | 1 |
| negative regulation of hydrolase activity | 1 |
| acrosomal vesicle | 1 |
| secretory granule membrane | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
174 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM225 | TMEM270 | Q6UE05 | 688 |
| TMEM225 | FSCN3 | Q9NQT6 | 673 |
| TMEM225 | TMEM225B | P0DP42 | 654 |
| TMEM225 | DHRS12 | A0PJE2 | 646 |
| TMEM225 | TMCO5A | Q8N6Q1 | 644 |
| TMEM225 | GTSF1L | Q9H1H1 | 641 |
| TMEM225 | GARIN1B | Q96KD3 | 626 |
| TMEM225 | SPATS1 | Q496A3 | 601 |
| TMEM225 | NUDT17 | P0C025 | 596 |
| TMEM225 | SPACA4 | Q8TDM5 | 582 |
| TMEM225 | SPATA3 | Q8NHX4 | 582 |
| TMEM225 | TRIM69 | Q86WT6 | 559 |
| TMEM225 | TRAFD1 | O14545 | 543 |
| TMEM225 | SLC22A14 | Q9Y267 | 474 |
| TMEM225 | UBQLN3 | Q9H347 | 474 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM225 | PPP1CA | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (1): TMEM225 (Affinity Capture-Western)
ESM2 similar proteins: A0A494BZU4, A0A7H0DND7, A0JNG0, A2T345, A4IIV4, C4QM85, E7F594, G5EDX4, O02051, O45306, P0DP42, P0DST5, P0DST6, P21061, P24763, P34362, P34363, P53053, Q09282, Q0II41, Q10907, Q11071, Q11085, Q13571, Q20249, Q297K8, Q2KHT4, Q2KJA5, Q32KQ5, Q5DC12, Q5GH77, Q5PQM0, Q5RD28, Q5REZ0, Q5TAH2, Q61168, Q6AXT9, Q6GV27, Q6GV28, Q7K1V5
Diamond homologs: Q32KQ5, Q6GV27, Q6GV28, Q9D9S2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
306 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:123885454:C:CT | donor_gain | 0.9700 |
| 11:123885477:T:TA | donor_gain | 0.9700 |
| 11:123885597:T:TA | donor_gain | 0.9700 |
| 11:123885451:C:CT | donor_gain | 0.9500 |
| 11:123883350:CTC:C | acceptor_gain | 0.8800 |
| 11:123885455:C:CT | donor_gain | 0.8500 |
| 11:123885605:T:TA | donor_gain | 0.8500 |
| 11:123885393:AC:A | donor_gain | 0.8400 |
| 11:123885394:CC:C | donor_gain | 0.8400 |
| 11:123885405:T:TA | donor_gain | 0.8300 |
| 11:123885592:AC:A | donor_gain | 0.8200 |
| 11:123885593:CC:C | donor_gain | 0.8200 |
| 11:123885418:TGC:T | donor_gain | 0.8000 |
| 11:123885492:G:C | donor_gain | 0.7900 |
| 11:123883350:CTCCT:C | acceptor_gain | 0.7700 |
| 11:123885602:A:AC | donor_gain | 0.7500 |
| 11:123885603:C:CC | donor_gain | 0.7500 |
| 11:123883349:ACTCC:A | acceptor_gain | 0.7400 |
| 11:123885519:T:A | donor_gain | 0.7100 |
| 11:123885604:T:C | donor_gain | 0.7100 |
| 11:123885452:C:CT | donor_gain | 0.7000 |
| 11:123883349:ACTC:A | acceptor_loss | 0.6800 |
| 11:123883352:CCTAG:C | acceptor_loss | 0.6800 |
| 11:123883353:CTAG:C | acceptor_loss | 0.6800 |
| 11:123883354:T:A | acceptor_loss | 0.6800 |
| 11:123883355:A:C | acceptor_loss | 0.6400 |
| 11:123885207:T:TA | donor_gain | 0.6400 |
| 11:123885598:C:A | donor_gain | 0.6400 |
| 11:123883366:A:C | acceptor_loss | 0.6300 |
| 11:123885242:G:T | donor_gain | 0.6100 |
AlphaMissense
1500 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:123885329:A:G | W33R | 0.960 |
| 11:123885329:A:T | W33R | 0.960 |
| 11:123884500:A:C | S106R | 0.959 |
| 11:123884500:A:T | S106R | 0.959 |
| 11:123884502:T:G | S106R | 0.959 |
| 11:123885278:A:G | W50R | 0.958 |
| 11:123885278:A:T | W50R | 0.958 |
| 11:123885282:A:C | S48R | 0.954 |
| 11:123885282:A:T | S48R | 0.954 |
| 11:123885284:T:G | S48R | 0.954 |
| 11:123885327:C:A | W33C | 0.948 |
| 11:123885327:C:G | W33C | 0.948 |
| 11:123885276:C:A | W50C | 0.947 |
| 11:123885276:C:G | W50C | 0.947 |
| 11:123885371:A:G | W19R | 0.937 |
| 11:123885371:A:T | W19R | 0.937 |
| 11:123884167:A:G | L124P | 0.932 |
| 11:123884599:G:C | S73R | 0.932 |
| 11:123884599:G:T | S73R | 0.932 |
| 11:123884601:T:G | S73R | 0.932 |
| 11:123885252:C:A | W58C | 0.932 |
| 11:123885252:C:G | W58C | 0.932 |
| 11:123885254:A:G | W58R | 0.922 |
| 11:123885254:A:T | W58R | 0.922 |
| 11:123884575:G:C | N81K | 0.921 |
| 11:123884575:G:T | N81K | 0.921 |
| 11:123884142:G:C | F132L | 0.918 |
| 11:123884142:G:T | F132L | 0.918 |
| 11:123884144:A:G | F132L | 0.918 |
| 11:123885319:A:G | L36S | 0.917 |
dbSNP variants (sampled 300 via entrez): RS1000561039 (11:123883725 C>T), RS1001158022 (11:123887655 A>C,G), RS1001357645 (11:123886481 C>T), RS1001808686 (11:123885275 T>TC), RS1001980701 (11:123886840 A>G), RS1002701947 (11:123885171 T>C), RS1003027939 (11:123884983 C>A,T), RS1003360031 (11:123883675 A>T), RS1004428768 (11:123886879 T>C), RS1004710550 (11:123885779 A>T), RS1004778701 (11:123887442 A>C), RS1005218231 (11:123887147 C>G,T), RS1006879862 (11:123885467 G>A,T), RS1007165645 (11:123883943 G>T), RS1007196046 (11:123882794 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001834_8 | Oleic acid (18:1n-9) levels | 3.000000e-06 |
| GCST004751_11 | Serum uric acid levels in response to allopurinol in gout | 3.000000e-06 |
| GCST004751_16 | Serum uric acid levels in response to allopurinol in gout | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004761 | uric acid measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| testosterone undecanoate | affects cotreatment, increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Levonorgestrel | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.